Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (71-80 of 245) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
British Journal of Cancer|March 1, 1983
The effects of regional factors on the growth rate and the differentiation of mouse teratocarcinomaJ W Oosterhuis, O Bagasra, H Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I studyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Cancer|January 8, 2005
Five-day courses of irinotecan as palliative therapy for patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|November 5, 2010
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecanBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Radiology|January 1, 1981
Ossification in a soft tissue embryonal rhabdomyosarcomaR C Brasch, O H Kim, J H Kushner, et al.
Cancer|September 15, 1990
Dose-intensive use of cyclophosphamide in ablation of neuroblastomaB H Kushner, R J O'Reilly, M LaQuaglia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 1995
Insulin sensitivity, lipids, and blood pressure in young American blacksB Falkner, H Kushner, T Tulenko, et al.
American Journal of Medical Genetics|July 31, 1995
Ullrich-Turner syndrome: neurodevelopmental changes from childhood through adolescenceJ L Ross, G Stefanatos, D Roeltgen, et al.
Pageof 25

Showing results (71-80 of 245) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
British Journal of Cancer|March 1, 1983
The effects of regional factors on the growth rate and the differentiation of mouse teratocarcinomaJ W Oosterhuis, O Bagasra, H Kushner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I studyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Cancer|January 8, 2005
Five-day courses of irinotecan as palliative therapy for patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|November 5, 2010
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecanBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Radiology|January 1, 1981
Ossification in a soft tissue embryonal rhabdomyosarcomaR C Brasch, O H Kim, J H Kushner, et al.
Cancer|September 15, 1990
Dose-intensive use of cyclophosphamide in ablation of neuroblastomaB H Kushner, R J O'Reilly, M LaQuaglia, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 1995
Insulin sensitivity, lipids, and blood pressure in young American blacksB Falkner, H Kushner, T Tulenko, et al.
American Journal of Medical Genetics|July 31, 1995
Ullrich-Turner syndrome: neurodevelopmental changes from childhood through adolescenceJ L Ross, G Stefanatos, D Roeltgen, et al.
Pageof 25